In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s ...
AbbVie officially began construction on its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, ...
GSK appoints Luke Miels as CEO designate, set to lead the company into a pivotal growth phase starting January 2026.
The founder of InflaRX discusses lessons learned during the COVID-19 pandemic and how they’re being applied in a ...
Genmab's acquisition of Merus for $8 billion enhances its oncology portfolio, promising growth and innovative therapies like ...
The FDA has expanded Johnson & Johnson’s Tremfya (guselkumab) approval to children six years and older weighing at least 40 ...
While the MFN executive order targets drug companies for drug prices, Peter Rubin discusses how health plans also play a ...
AstraZeneca aims to harmonize its share listings globally to enhance sustainable growth and investor reach, maintaining headquarters in the UK. Enhertu shows superior outcomes in early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback